Annual Drug Patent Expirations for BENICAR
Benicar is a drug marketed by Daiichi Sankyo and is included in two NDAs. It is available from three suppliers.
Drug patent litigation for BENICAR.
The generic ingredient in BENICAR is hydrochlorothiazide; olmesartan medoxomil. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; olmesartan medoxomil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
